Finding the perfect match: How high performance materials for secondary packaging components can significantly reduce particle contamination in ready-to-use vials
Download our whitepaper to learn how to minimize contamination risks in parenteral drug packaging!
Did you know that between 2017 and 2021, approximately 50% of all parenteral drug-related recalls were due to particles and insufficient sterility assurance? Ready-to-use (RTU) packaging offers a significant advantage by reducing particle generation compared to traditional bulk filling lines. However, selecting the ideal secondary packaging materials—such as the nest—remains critical in ensuring sterility and safety.
Read the full whitepaper to explore best practices for contamination control and optimal packaging choices!
Did you know that between 2017 and 2021, approximately 50% of all parenteral drug-related recalls were due to particles and insufficient sterility assurance? Ready-to-use (RTU) packaging offers a significant advantage by reducing particle generation compared to traditional bulk filling lines. However, selecting the ideal secondary packaging materials—such as the nest—remains critical in ensuring sterility and safety.
Read the full whitepaper to explore best practices for contamination control and optimal packaging choices!
